Greenwich LifeSciences Inc Stock price
Is Greenwich LifeSciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Greenwich LifeSciences Inc Stock Analysis
Analyst Opinions
8 Analysts have issued a Greenwich LifeSciences Inc forecast:
Analyst Opinions
8 Analysts have issued a Greenwich LifeSciences Inc forecast:
Don't miss a Thing! We will send you all news about Greenwich LifeSciences Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Greenwich LifeSciences Inc Stock News
Company Profile
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
| Head office | United States |
| CEO | Mr. Patel |
| Employees | 6 |
| Founded | 2006 |
| Website | greenwichlifesciences.com |


